secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001178913-24-003536
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward expands board to seven, appoints Robert J. Marshall Jr. as director and Audit Committee chair
--------------------------------------------------------------------------------

- Board expanded from six to seven directors, effective November 2, 2024.
- Robert J. Marshall Jr., CFO of Lantheus Holdings (public radiopharmaceutical co.), appointed as Class III director and Audit Committee chair.
- Mr. Marshall previously held senior finance roles at Zimmer Biomet for 16 years; holds CFA designation.
- He qualifies as independent under Nasdaq listing rules; no related party transactions disclosed.
- Director compensation follows standard non-employee director terms per most recent proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891324003536/0001178913-24-003536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891324003536/zk2431990.htm
  HTML page:      https://secwatch.observer/filing/0001178913-24-003536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer